Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have a higher chance of experiencing depression, anxiety, and sleep disorders.

High doses of cyproterone acetate are linked to an increased risk of developing meningioma.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Premature hair graying in young Turkish adults is more likely if they have stress, a family history of graying, drink alcohol, have chronic diseases, are older, or are taller.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

Breathing in high levels of certain air pollutants significantly increases women's risk of developing Polycystic Ovary Syndrome.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

Valproic acid increases the risk of hair loss more than other drugs, especially in migraine patients, and lamotrigine may be a safer alternative.

Trichotillomania was successfully treated with risperidone and naltrexone.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Finasteride may increase the risk of depression, anxiety, and suicidal thoughts.

Some skin, hair, and nail supplements can be toxic, interact with medications, affect lab tests, and may increase cancer risk.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

Stem cells show promise for hair loss and skin treatments in aesthetics but need more research on safety and standard methods.

Taking 5 alpha reductase inhibitor medication slightly increases the risk of depression, especially as you get older.

Finasteride doesn't raise acute pancreatitis risk.

Long-term use of Risperidone may be linked to a serious skin condition in bipolar patients, affecting their overall well-being.

Lurasidone is effective for bipolar depression and schizophrenia, but more safety data is needed.

Hutchinson-Gilford Progeria Syndrome is a rare genetic disorder caused by a specific gene mutation, characterized by aging symptoms and managed by monitoring heart health and using low-dose aspirin.

A teenage girl's excessive hair growth was caused by a medication for mania, but improved after stopping the medication.

CD133+ progenitor cells have therapeutic potential for diabetic ulcers and heart attack recovery, with manageable risks.

Bupropion causes more hair loss than other antidepressants, with paroxetine causing the least.

Weight loss and low folic acid levels after sleeve gastrectomy can predict hair loss severity.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

Men taking dutasteride may have a higher risk of age-related macular degeneration.